Navigation Links
PCAS : Tighter Links Between PCAS and Proteus

LONGJUMEAU, France, October 22 /PRNewswire-FirstCall/ -- Proteus today announced the completion of a share capital increase reserved for Proteus' industrial partner PCAS. PCAS' stake in Proteus now represents 32% of the issued share capital vs 6% before the increase. Proceeds of this private placement are to be used to accelerate the growth of PROTEUS' PSI and PCAS BIOSOLUTION businesses.

PROTEUS ( is a biotech company discovering, optimizing, developing and producing new proteins and biotechnological processes for pharmaceuticals, cosmetics, fine chemicals, environmental and other industrial applications. PROTEUS' business is backed by a unique set of technologies, know how and intellectual property portfolio including exclusive resources in natural microbial biodiversity and proprietary technologies for screening, engineering and producing proteins.

PROTEUS offers a range of exclusive solutions for protein manufacturing and engineering through a dedicated business unit "PSI" (Proteus Services for Industry) and through exclusive industrial partnerships. The new proteins and process developed by PROTEUS reinforce the competitive edge and intellectual property position of its clients.

PCAS and PROTEUS already entered into close partnership by forming PCAS BIOSOLUTION, a 50/50 joint venture. The mission of PCAS BIOSOLUTION ( is to design, develop and industrialize new manufacturing routes to produce pharmaceutical intermediates and actives compounds ("API"). The new routes combines chemical processes developed by PCAS and enzymatic catalytic processes ("biocatalysis") developed by PROTEUS.

PCAS thus reinforces its position in "green chemistry", providing its clients with all the benefits of integrating chemistry and biotechnology. The new chemo-biocatalytic processes developed at PCAS BIOSOLUTION enable to access to complex pharmaceutical intermediates while reducing the number of steps of the manufacturing process, lowering the production costs and reducing the amount of waste. With PCAS BIOSOLUTION, PROTEUS improves and widens its offering to the life science industry by providing industrial manufacturing services backed by the expertise and industrial capabilities of PCAS, a leading European player in the field.

PCAS ( is a group listed on the Eurolist compartment C (ISIN FR0000053514), specialized in fine and specialty chemicals. It develops and manufactures high added-value molecules or molecules of a strong technological content for the pharmaceutical, perfume, cosmetic and industrial sectors.

Contact :

GĂ©rard Guillamot,


Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Investor links East Coast funds to Midwest tech
2. UW links with Israeli school to locate genes
3. New Dane County airport links to Atlanta announced
4. Big collaboration links learners to science on a tiny scale
5. ARI Links e-Catalog Deal with Outdoor Power Equipment Manufacturer
6. PCR Performance Comparisons Between pfuturbo and Taq DNA Polymerases
7. Quantitative Measurement of Cell Proliferation Using the BrdU ELISA: A Comparison Between Colorimetric and Chemiluminescent Detection
8. Monitoring fluorescence resonance energy transfer (FRET) between GFP fusions in lysates of the yeast Saccharomyces cerevisiae using the Varian Cary Eclipse
9. Comparison of Performance between the AlphaQuest - HTS and the Fusion α Multilabel Reader for Detection of cAMP
10. Single gene controls key difference between maize and its wild ancestor
11. Line between big pharma, big biotech continues to blur
Post Your Comments:
(Date:11/25/2015)... , Nov. 25, 2015 Orexigen® Therapeutics, ... will participate in a fireside chat discussion at the ... New York . The discussion is scheduled for ... .  A replay will be available ... Contact:McDavid Stilwell  , Julie NormartVP, Corporate Communications and ...
(Date:11/24/2015)... LUMPUR, Malaysia , Nov. 24, 2015 /PRNewswire/ ... global contract research organisation (CRO) market. The trend ... result in lower margins but higher volume share ... increased capacity and scale, however, margins in the ... Research Organisation (CRO) Market ( ), ...
(Date:11/24/2015)... SAN DIEGO , Nov. 24, 2015 Halozyme Therapeutics, ... Jaffray Healthcare Conference in New York on ... Dr. Helen Torley , president and CEO, will provide a ... New York at 1:00 p.m. ET/10:00 a.m. ... communication and investor relations, will provide a corporate overview. --> ...
(Date:11/24/2015)... ... November 24, 2015 , ... International Society ... one of the premier annual events for pharmaceutical manufacturing: 2015 Annual Meeting. The ... where ISPE hosted the largest number of attendees in more than a decade. ...
Breaking Biology Technology:
(Date:11/4/2015)... , November 4, 2015 ... market report published by Transparency Market Research "Home Security Solutions ... and Forecast 2015 - 2022", the global home security solutions ... bn by 2022. The market is estimated to expand ... from 2015 to 2022. Rising security needs among customers ...
(Date:10/29/2015)... , Oct. 29, 2015 Daon, a ... that it has released a new version of its ... in North America have already ... v4.0 also includes a FIDO UAF certified server ... already preparing to activate FIDO features. These customers include ...
(Date:10/29/2015)... Oct. 29, 2015 Today, LifeBEAM ... partnership with 2XU, a global leader in technical ... smart hat with advanced bio-sensing technology. The hat ... to monitor key biometrics to improve overall training ... the two companies will bring together the most advanced ...
Breaking Biology News(10 mins):